Portage Biotech Inc. Files Form 6-K
Ticker: ATON · Form: 6-K · Filed: Nov 26, 2024 · CIK: 1095435
| Field | Detail |
|---|---|
| Company | Portage Biotech INC. (ATON) |
| Form Type | 6-K |
| Filed Date | Nov 26, 2024 |
| Risk Level | low |
| Pages | 1 |
| Reading Time | 1 min |
| Sentiment | neutral |
Sentiment: neutral
Topics: reporting, foreign-private-issuer, sec-filing
Related Tickers: PORT
TL;DR
Portage Biotech Inc. (PORT) filed a 6-K on Nov 26, 2024. Standard reporting update.
AI Summary
Portage Biotech Inc. filed a Form 6-K on November 26, 2024, reporting for the month of November 2024. The company, incorporated in the British Virgin Islands, is a pharmaceutical preparations company. This filing is a report of a foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934.
Why It Matters
This filing indicates ongoing reporting requirements for Portage Biotech Inc. as a foreign private issuer, providing updates to investors and the SEC.
Risk Assessment
Risk Level: low — This filing is a routine report and does not contain new material financial information or significant operational changes.
Key Players & Entities
- Portage Biotech Inc. (company) — Filer
- 001-40086 (company) — SEC File Number
- 20241126 (date) — Filing Date
- November 2024 (date) — Reporting Period
FAQ
What is the purpose of a Form 6-K filing?
A Form 6-K is a report of a foreign private issuer filed with the SEC to provide information that the company has made or is required to make public in its home country, or has filed or is required to file with a stock exchange on which its securities are traded.
What is Portage Biotech Inc.'s standard industrial classification?
Portage Biotech Inc.'s Standard Industrial Classification is Pharmaceutical Preparations [2834].
When was Portage Biotech Inc. incorporated?
The filing does not explicitly state the incorporation date, but it indicates the company's fiscal year end is March 31st and it is incorporated in D8 (British Virgin Islands).
What is the principal executive office address for Portage Biotech Inc.?
The principal executive offices are located at Clarence Thomas Building, P.O. Box 4649, Road Town, Tortola, British Virgin Islands, VG1110.
Does Portage Biotech Inc. file annual reports under Form 20-F or 40-F?
Portage Biotech Inc. indicates it files annual reports under cover of Form 20-F.
Filing Stats: 320 words · 1 min read · ~1 pages · Grade level 10.2 · Accepted 2024-11-26 16:15:17
Filing Documents
- f6k_112624.htm (6-K) — 14KB
- exh_991.htm (EX-99.1) — 675KB
- exh_992.htm (EX-99.2) — 306KB
- novelpipeline.jpg (GRAPHIC) — 27KB
- engagerplatform.jpg (GRAPHIC) — 37KB
- singleagentactivity.jpg (GRAPHIC) — 49KB
- 0001171843-24-006599.txt ( ) — 4359KB
- ptgef-20240930.xsd (EX-101.SCH) — 64KB
- ptgef-20240930_cal.xml (EX-101.CAL) — 52KB
- ptgef-20240930_def.xml (EX-101.DEF) — 131KB
- ptgef-20240930_lab.xml (EX-101.LAB) — 259KB
- ptgef-20240930_pre.xml (EX-101.PRE) — 240KB
- f6k_112624_htm.xml (XML) — 602KB
Management's Discussion and Analysis for the three and six months ended
Management's Discussion and Analysis for the three and six months ended September 30, 2024. 101.INS Inline XBRL Instance Document. 101.SCH Inline XBRL Taxonomy Extension Schema Document. 101.CAL Inline XBRL Taxonomy Extension Calculation Linkbase Document 101.DEF Inline XBRL Taxonomy Definition Linkbase Document 101.LAB Inline XBRL Taxonomy Extension Label Linkbase Document 101.PRE Inline XBRL Taxonomy Extension Presentation Linkbase Document 104 Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101)
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. Date: November 26, 2024 PORTAGE BIOTECH INC. By: /s/ Andrea Park Andrea Park Chief Financial Officer